Search clinical trials for: Extended Release Opioid Formulation, Shortened Intervals
Total 119 results
-
University Health Network, TorontoCanadian Society of Hospital PharmacistsWithdrawn
-
ApoPharmaCompleted
-
UCB PharmaCompletedEpilepsyBrazil, Finland, India, Mexico, Russian Federation, South Africa, Ukraine
-
Janssen Korea, Ltd., KoreaCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Massachusetts General HospitalCompletedAutism Spectrum Disorder | Attention-deficit/Hyperactivity DisorderUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Washington University School of MedicineTerminatedSpastic Cerebral PalsyUnited States
-
Friends Research Institute, Inc.RecruitingOpioid-use DisorderUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Actavis Inc.CompletedHealthyUnited States
-
Actavis Inc.Completed
-
OBEcure Ltd.Completed
-
Université de MontréalLabopharm Inc.; MDS Pharma ServicesCompleted
-
University of RochesterTerminated
-
Zogenix, Inc.Completed
-
AbbVie (prior sponsor, Abbott)Completed
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Royal Victoria Hospital, CanadaNot yet recruitingModerate to Severe Opioid Use DisorderCanada
-
AbbottCompleted
-
Endo PharmaceuticalsCompletedPain | Chronic Disease
-
Purdue Pharma LPTerminatedChronic Non-Malignant PainUnited States
-
Zogenix, Inc.Completed
-
PfizerCompletedPainUnited States, Puerto Rico
-
PfizerCompletedOsteoarthritis of the KneeUnited States
-
Indivior Inc.CompletedOpioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
NYU Langone HealthHarvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaboratorsRecruitingOpioid Use Disorder (OUD)United States
-
Endo PharmaceuticalsCompleted
-
Endo PharmaceuticalsCompletedChronic PainUnited States
-
New York State Psychiatric InstituteCompletedOpioid-use DisorderUnited States
-
Brigham and Women's HospitalNational Institute on Drug Abuse (NIDA); Arthritis FoundationCompletedDepression | Anxiety | Degenerative Disc Disease | Chronic Low Back PainUnited States
-
Indivior Inc.CompletedOpioid Use DisorderUnited States
-
University of Texas Southwestern Medical CenterNational Institute on Drug Abuse (NIDA)RecruitingCocaine Use DisorderUnited States
-
AbbVie (prior sponsor, Abbott)CompletedChronic Low Back PainUnited States
-
Endo PharmaceuticalsCompletedCancer | Chronic Pain | Neuropathic Pain
-
Hennepin Healthcare Research InstituteNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCRecruitingSubstance Use Disorder | Opioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
AbbVie (prior sponsor, Abbott)CompletedChronic Low Back PainUnited States
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA)Withdrawn
-
Tocagen Inc.Withdrawn
-
Indivior Inc.Active, not recruitingModerate to Severe Opioid-use DisorderUnited States, Canada
-
University of Colorado, DenverCompletedScoliosis | Pain Management | Spinal FusionUnited States
-
Indivior Inc.Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbHCompleted